Soybean oil is widely used as medicine solvent for intramuscular injection, or as component of emulsion for total nutrition transfusion, and as edible oil. Soybean oil is considered to be a completely non-toxic and non-irritating substance.
Market Analysis and Insights: Global Soybean Oil (Pharma Grade) Market
Due to the COVID-19 pandemic, the global Soybean Oil (Pharma Grade) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Soybean Oil ( For Injection) accounting for % of the Soybean Oil (Pharma Grade) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Drug segment is altered to an % CAGR throughout this forecast period.
China Soybean Oil (Pharma Grade) market size is valued at US$ million in 2021, while the US and Europe Soybean Oil (Pharma Grade) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Soybean Oil (Pharma Grade) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Soybean Oil (Pharma Grade) include Guangzhou Hanfang Pharmaceutical, ADM-SIO, Zhejiang Tianyushan Medicinal Oil, Xinxing Pharma (Yaopharma), XIAN TIANZHENG MEDICINAL MATERIALS, XIAN TAIHUA and Shanxi Shangping Medicinal Accessories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Soybean Oil (Pharma Grade) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Soybean Oil (Pharma Grade) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Soybean Oil (Pharma Grade) Scope and Segment
Soybean Oil (Pharma Grade) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Soybean Oil (Pharma Grade) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Soybean Oil ( For Injection)
Soybean Oil ( For Oral)
Segment by Application
Drug
Health Products
Veterinary Drugs
By Company
Guangzhou Hanfang Pharmaceutical
ADM-SIO
Zhejiang Tianyushan Medicinal Oil
Xinxing Pharma (Yaopharma)
XIAN TIANZHENG MEDICINAL MATERIALS
XIAN TAIHUA
Shanxi Shangping Medicinal Accessories
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE